![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: John Wiley & Sons Inc
E-ISSN: 2055-2335|33|2|106-110
ISSN: 1445-937x
Source: JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.33, Iss.2, 2003-06, pp. : 106-110
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The cost of adverse drug reactions
By Gautier Sophie Bachelet Hélène Bordet Régis Caron Jacques
Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 3, 2003-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Expert Opinion on Drug Safety, Vol. 2, Iss. 4, 2003-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adverse drug reactions during pregnancy
Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
First Reports of Adverse Drug Reactions
International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 6, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The pharmacogenetic basis of adverse drug reactions
By John C.
International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. :